non_COVID_19_healthy_vs_non_critical_COVID_19

Profile details

Identifier: MTBLS1866_0003_00000001
Linked study: MTBLS1866 — Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
Comparison: non-COVID-19 healthy vs non-critical COVID-19
Group A: Samples from healthy individuals without COVID-19.. Provides a baseline for identifying metabolic changes due to COVID-19.
Group B: Samples from non-critical COVID-19 patients.. Understanding the metabolic profile of non-critical COVID-19 patients helps in identifying potential biomarkers and therapeutic targets.
Total features tested: 201
Significant features: 91
p-value threshold: 0.05
Ratio threshold (upper): 1.5
Ratio threshold (lower): 1/1.5
Date created: 2025-09-26 00:00:00

Metabolite ID (InChI Key)	Name	Direction	Ratio	p-value
MIEYBHWKRILIAE-JUUZHAOZSA-N	1-(11<i>Z</i>-octadecenoyl)-2-(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>-docosahexaenoyl)-<em>sn</em>-glycero-3-phosphoethanolamine	up	8.814	1.96e-15
SOYNLLDADLOGAM-ISLYRVAYSA-N	trans-2-Hexadecenoyl-carnitine	up	3.893	2.01e-16
ZSWHHKKYMMYPPD-MSZSINMWSA-N	GPCho(15:0/20:4w6)	up	3.684	1.55e-14
PVOQPLSKYNZHOT-SEYXRHQNSA-N	(11<i>Z</i>)-icoseneoylcarnitine	up	5.391	6.64e-11
IYZLSPKVBGVQGT-KDMZTRHFSA-N	[(2S)-1-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropan-2-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate	down	0.08364	2.94e-07
YGOMWJXISJKIPY-CJZWHCSYSA-N	1-Myristoyl-2-eicosadienoyl-sn-glycerol	up	4.934	1.37e-10
PSHXNVGSVNEJBD-LJQANCHMSA-N	(<i>R</i>)-myristoylcarnitine	up	2.715	4.2e-14
IPOLTUVFXFHAHI-SEYXRHQNSA-N	3-[(9<i>Z</i>)-octadec-9-enoyloxy]-4-(trimethylammonio)butanoate	up	3.45	2.05e-11
DBCKADUSYJAPII-LJURNQLPSA-O	[3-carboxy-2-[(5Z,8Z,11Z)-icosa-5,8,11-trienoyl]oxypropyl]-trimethylazanium	up	6.732	3.03e-07
RBFQHRALHSUPIA-SNPVRQPZSA-N	3-[(5<i>Z</i>,8<i>Z</i>,11<i>Z</i>,14<i>Z</i>)-icosa-5,8,11,14-tetraenoyloxy]-4-(trimethylammonio)butanoate	up	5.162	3.5e-08